DAX21.773 -0,9%ESt505.054 -0,9%Top 10 Crypto11,91 -4,4%Dow39.607 +1,1%Nas16.708 +2,5%Bitcoin80.921 -2,0%Euro1,1380 +0,5%Öl66,73 +0,9%Gold3.334 +1,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Tesla A1CX3T RENK RENK73 SAP 716460 BYD A0M4W9 Lufthansa 823212 Amazon 906866 Mercedes-Benz Group (ex Daimler) 710000 Apple 865985 Volkswagen (VW) vz. 766403 BASF BASF11 Siemens Energy ENER6Y Allianz 840400 Infineon 623100
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Berichtssaison im Blick: DAX verliert -- Asiens Börsen uneinheitlich -- adidas steigert Umsatz und Gewinn -- Roche, Nestlé, Commerzbank, Nokia, EVOTEC & Tesla im Fokus
Top News
Vossloh-Aktie knickt ein: Schwacher Jahresstart Vossloh-Aktie knickt ein: Schwacher Jahresstart
Ifo-Geschäftsklima überrascht im April mit leichtem Anstieg Ifo-Geschäftsklima überrascht im April mit leichtem Anstieg
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Die Top 10 Coins im Depot - mit dem finanzen.net Top 10 Crypto ETP. Jetzt informieren!

Halozyme Therapeutics Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
51,24 EUR -0,70 EUR -1,35 %
FSE
58,40 USD +0,21 USD +0,36 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.6,34 Mrd. EUR

KGV13,93Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0DLHS

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS40637H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolHALO

Halozyme Therapeutics Aktien News

DatumMeistgelesen
PR NewswireHalo Announces Update to Proposed Share Consolidation
PR NewswireHalo Collective Completes Acquisition of Premium Indoor Grow and Distribution Hub in Portland, Oregon
PR NewswireHalo Collective and Alpha Blue Ocean Agree to Early Termination of Loan and Convertible Debentures Agreements
PR NewswireHalozyme to Participate in the 2022 Wells Fargo Healthcare Conference
PR Newswire/R E P E A T -- Halo Collective Appoints Katie Field as Chairman of the Board/
PR NewswireHalo Collective Appoints Katie Field as Chairman of the Board
PR NewswireHalo Collective Receives All Regulatory Approvals for its Third Budega™ Dispensary in Hollywood, Halo's first Superstore
PR NewswireHALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS
PR NewswireHalo Collective Congrats Akanda Corp. on Cansativa Supply Agreement for Europe
PR NewswirePositive Results Announced from Phase III IMscin001 Study Evaluating Subcutaneous Formulation of Tecentriq® with ENHANZE® in Advanced Non-Small Cell Lung Cancer
PR NewswireHalozyme to Report Second Quarter 2022 Financial and Operating Results
PR NewswireHalo Collective Promotes Katharyn Field to Chief Executive Officer
PR NewswireHalo Collective Promotes Katharyn Field to Chief Executive Officer
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireHalo Announces Results of Annual General and Special Meeting
PR NewswireHalo Announces Results of Annual General and Special Meeting
PR NewswireHalozyme to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
PR NewswireHalozyme Announces Commercial Launch of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
PR NewswireHalozyme Completes Antares Pharma Acquisition
PR NewswireHalo Collective's Budega™ Dispensary in Westwood to Open May 27 and Hollywood Planned for June
PR Newswire/C O R R E C T I O N from Source -- Halo Collective Inc./
PR Newswire/C O R R E C T I O N from Source -- Halo Collective Inc./
PR NewswireHalo Collective's BudegaTM Westwood Dispensary to Open May 27
PR NewswireHalo Collective's BudegaTM Westwood Dispensary to Open May 27
PR NewswireHalo Collective to Host Earnings Call Today at 4:15pm EST for First Quarter 2022 Financial Results
PR NewswireHalo Collective to Host Earnings Call Today at 4:15pm EST for First Quarter 2022 Financial Results
PR Newswire/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/
PR Newswire/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/
PR NewswireHalo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)
PR NewswireHalo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)
PR NewswireHart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma
PR NewswireHalozyme Reports First Quarter 2022 Results
PR Newswire/R E P E A T -- Halo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening/
PR Newswire/R E P E A T -- Halo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening/
PR NewswireHalo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening
PR NewswireHalo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening
PR NewswireHalozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call
PR NewswireHalo Collective Announces Filing of Halo Tek Prospectus and Change in Chief Financial Officer and Board of Directors
Wer­bung

Halozyme Therapeutics News

Halozyme Therapeutics News: auf dieser Seite finden Sie alle Halozyme Therapeutics News und Nachrichten zur Halozyme Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Halozyme Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Halozyme Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.